Advisory Committee on Actuarial Examinations; Vacancy, 72792-72793 [2023-23328]
Download as PDF
<![CDATA[
72792
Federal Register / Vol. 88, No. 203 / Monday, October 23, 2023 / Notices
identified in ADDRESSES. Requests for
repatriation may be submitted by:
1. Any one or more of the Indian
Tribes or Native Hawaiian organizations
identified in this notice.
2. Any lineal descendant, Indian
Tribe, or Native Hawaiian organization
not identified in this notice who shows,
by a preponderance of the evidence, that
the requestor is a lineal descendant or
a culturally affiliated Indian Tribe or
Native Hawaiian organization.
Repatriation of the human remains in
this notice to a requestor may occur on
or after November 22, 2023. If
competing requests for repatriation are
received, the Field Museum must
determine the most appropriate
requestor prior to repatriation. Requests
for joint repatriation of the human
remains are considered a single request
and not competing requests. The Field
Museum is responsible for sending a
copy of this notice to the Indian Tribe
identified in this notice.
Authority: Native American Graves
Protection and Repatriation Act, 25
U.S.C. 3003, and the implementing
regulations, 43 CFR 10.9, 10.10, and
10.14.
In the Federal Register of October 2,
2023, in FR Doc. 2023–21579 (88 FR
67796), on page 67796, in the third
column, correct the date of the
Committee meeting to read: ‘‘Thursday,
November 9, 2023.’’
Alma Ripps,
Chief, Office of Policy.
[FR Doc. 2023–23360 Filed 10–20–23; 8:45 am]
BILLING CODE 4312–52–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–23–050]
Sunshine Act Meetings
United
States International Trade Commission.
AGENCY HOLDING THE MEETING:
TIME AND DATE:
October 26, 2023 at 9:30
a.m.
Room 101, 500 E Street SW,
Washington, DC 20436, Telephone:
(202) 205–2000.
Open to the public.
[FR Doc. 2023–23278 Filed 10–20–23; 8:45 am]
STATUS:
BILLING CODE 4312–52–P
MATTERS TO BE CONSIDERED:
DEPARTMENT OF THE INTERIOR
National Park Service
[NPS–NERO–GATE–36747; PPNEGATEB0,
PPMVSCS1Z.Y00000]
Notice of Cancellation and
Rescheduling of the Public Meeting of
the Gateway National Recreation Area
Fort Hancock 21st Century Advisory
Committee; Correction
National Park Service, Interior.
ACTION: Notice; correction.
AGENCY:
The National Park Service
published in the Federal Register on
October 2, 2023, a notice of public
meeting of the Gateway National
Recreation Area Fort Hancock 21st
Century Advisory Committee scheduled
for November 16, 2023. The document
contained an incorrect date. The date of
the meeting is November 9, 2023.
FOR FURTHER INFORMATION CONTACT:
Daphne Yun, Acting Public Affairs
Officer, Gateway National Recreation
Area, 210 New York Avenue, Staten
Island, New York 10305, by telephone
(718) 815–3651, or by email daphne_
yun@nps.gov.
SUMMARY:
VerDate Sep<11>2014
17:24 Oct 20, 2023
Jkt 262001
JOINT BOARD FOR THE
ENROLLMENT OF ACTUARIES
Correction
PLACE:
Dated: October 11, 2023.
Melanie O’Brien,
Manager, National NAGPRA Program.
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
1. Agendas for future meetings: none.
2. Minutes.
3. Ratification List.
4. Commission vote on Inv. No. 731–
TA–921 (Fourth Review) (Folding Gift
Boxes from China). The Commission
currently is scheduled to complete and
file its determinations and views of the
Commission on November 3, 2023.
5. Outstanding action jackets: none.
CONTACT PERSON FOR MORE INFORMATION:
Sharon Bellamy, Supervisory Hearings
and Information Officer, 202–205–2000.
The Commission is holding the
meeting under the Government in the
Sunshine Act, 5 U.S.C. 552(b). In
accordance with Commission policy,
subject matter listed above, not disposed
of at the scheduled meeting, may be
carried over to the agenda of the
following meeting.
By order of the Commission.
Issued: October 19, 2023.
Sharon Bellamy,
Supervisory Hearings and Information
Officer.
[FR Doc. 2023–23419 Filed 10–19–23; 11:15 am]
BILLING CODE 7020–02–P
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Advisory Committee on Actuarial
Examinations; Vacancy
Joint Board for the Enrollment
of Actuaries.
ACTION: Request for applications.
AGENCY:
The Joint Board for the
Enrollment of Actuaries (Joint Board),
established under the Employee
Retirement Income Security Act of 1974
(ERISA), is responsible for the
enrollment of individuals who wish to
perform actuarial services under ERISA.
To assist in its examination duties
mandated by ERISA, the Joint Board has
established the Advisory Committee on
Actuarial Examinations (Advisory
Committee) in accordance with the
provisions of the Federal Advisory
Committee Act (FACA). The current
Advisory Committee members’ terms
expire on February 28, 2025. Recently,
a vacancy became available on the
Advisory Committee, and the Joint
Board seeks applications to fill that
vacancy. This notice describes the
Advisory Committee and invites
applications from those interested in
serving on the Advisory Committee for
the period March 1, 2024–February 28,
2025.
DATES: Applications for membership on
the Advisory Committee must be
received by December 1, 2023.
ADDRESSES: Send applications
electronically with APPLICATION FOR
ADVISORY COMMITTEE inserted in
subject line to NHQJBEA@irs.gov. See
SUPPLEMENTARY INFORMATION for
application requirements.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Van Osten, Designated Federal
Officer, Advisory Committee on
Actuarial Examinations, at 202–317–
3648 or elizabeth.j.vanosten@irs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
1. Background
To qualify for enrollment to perform
actuarial services under ERISA, an
applicant must satisfy certain
experience and knowledge
requirements, which are set forth in the
Joint Board’s regulations. An applicant
may satisfy the knowledge requirement
by successful completion of Joint Board
examinations in basic actuarial
mathematics and methodology and in
actuarial mathematics and methodology
relating to pension plans qualifying
under ERISA.
The Joint Board, the Society of
Actuaries, and the American Society of
Pension Professionals & Actuaries
jointly offer examinations acceptable to
E:\FR\FM\23OCN1.SGM
23OCN1
72793
Federal Register / Vol. 88, No. 203 / Monday, October 23, 2023 / Notices
the Joint Board for enrollment purposes
and acceptable to the other two actuarial
organizations as part of their respective
examination programs.
2. Scope of Advisory Committee Duties
The Advisory Committee plays an
integral role in the examination program
by assisting the Joint Board in offering
examinations that enable examination
candidates to demonstrate the
knowledge necessary to qualify for
enrollment. The Advisory Committee’s
duties, which are strictly advisory,
include (1) recommending topics for
inclusion on the Joint Board
examinations, (2) developing and
reviewing examination questions, (3)
recommending proposed examinations,
(4) reviewing examination results and
recommending passing scores, and (5)
providing other recommendations and
advice relative to the examinations, as
requested by the Joint Board.
lotter on DSK11XQN23PROD with NOTICES1
3. Member Terms and Responsibilities
Generally, members are appointed for
a 2-year term. However, the member
selected pursuant to this notice will be
appointed for 12 months, beginning
March 1, 2024. Members may seek
reappointment for additional
consecutive terms.
Members are expected to attend
approximately 4 meetings each calendar
year and are reimbursed for travel
expenses in accordance with applicable
government regulations. For this
appointment, the member is expected to
attend approximately 4 meetings.
Meetings may be held in-person or by
teleconference. In general, members are
expected to devote 125 to 175 hours,
including meeting time, to the work of
the Advisory Committee over the course
of a year.
4. Member Selection
The Joint Board seeks to appoint an
Advisory Committee that is fairly
balanced in terms of points of view
represented and functions to be
performed. Every effort is made to
ensure that most points of view extant
in the enrolled actuary profession are
represented on the Advisory Committee.
To that end, the Joint Board seeks to
appoint members from each of the main
practice areas of the enrolled actuary
profession, including small employer
plans, large employer plans, and
multiemployer plans. In addition, to
ensure diversity of points of view, the
Joint Board limits the number of
members affiliated with any one
actuarial organization or employed with
any one firm.
Membership normally will be limited
to actuaries currently enrolled by the
VerDate Sep<11>2014
17:24 Oct 20, 2023
Jkt 262001
Joint Board. However, individuals
having academic or other special
qualifications of particular value for the
Advisory Committee’s work also will be
considered for membership. Federally
registered lobbyists and individuals
affiliated with Joint Board enrollment
examination preparation courses are not
eligible to serve on the Advisory
Committee.
5. Member Designation
Advisory Committee members are
appointed as Special Government
Employees (SGEs). As such, members
are subject to certain ethical standards
applicable to SGEs. Upon appointment,
each member will be required to
provide written confirmation that he/
she does not have a financial interest in
a Joint Board examination preparation
course. In addition, each member will
be required to attend annual ethics
training.
6. Application Requirements
To receive consideration, an
individual interested in serving on the
Advisory Committee must submit (1) a
signed, cover letter expressing interest
in serving on the Advisory Committee
and describing his/her professional
qualifications, and (2) a resume and/or
curriculum vitae. Applications must be
submitted electronically to NHQJBEA@
irs.gov. The transmittal email should
include APPLICATION FOR ADVISORY
COMMITTEE in the subject line.
Applications must be received by
December 1, 2023.
Dated: October 18, 2023.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the
Enrollment of Actuaries.
[FR Doc. 2023–23328 Filed 10–20–23; 8:45 am]
BILLING CODE 4830–01–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1284]
Importer of Controlled Substances
Application: Nexus Pharmaceuticals,
Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Nexus Pharmaceuticals, Inc.
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
SUMMARY:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 22, 2023. Such
persons may also file a written request
for a hearing on the application on or
before November 22, 2023.
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on September 20, 2023,
Nexus Pharmaceuticals, Inc., 10300
128th Avenue, Pleasant Prairie,
Wisconsin 53158–7336 applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug
code
Schedule
Remifentanil ..................
9739
II
The company plans to import the
listed controlled substance for research
and analytical testing purposes. No
other activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
E:\FR\FM\23OCN1.SGM
23OCN1
]]>Agencies
[Federal Register Volume 88, Number 203 (Monday, October 23, 2023)]
[Notices]
[Pages 72792-72793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23328]
=======================================================================
-----------------------------------------------------------------------
JOINT BOARD FOR THE ENROLLMENT OF ACTUARIES
Advisory Committee on Actuarial Examinations; Vacancy
AGENCY: Joint Board for the Enrollment of Actuaries.
ACTION: Request for applications.
-----------------------------------------------------------------------
SUMMARY: The Joint Board for the Enrollment of Actuaries (Joint Board),
established under the Employee Retirement Income Security Act of 1974
(ERISA), is responsible for the enrollment of individuals who wish to
perform actuarial services under ERISA. To assist in its examination
duties mandated by ERISA, the Joint Board has established the Advisory
Committee on Actuarial Examinations (Advisory Committee) in accordance
with the provisions of the Federal Advisory Committee Act (FACA). The
current Advisory Committee members' terms expire on February 28, 2025.
Recently, a vacancy became available on the Advisory Committee, and the
Joint Board seeks applications to fill that vacancy. This notice
describes the Advisory Committee and invites applications from those
interested in serving on the Advisory Committee for the period March 1,
2024-February 28, 2025.
DATES: Applications for membership on the Advisory Committee must be
received by December 1, 2023.
ADDRESSES: Send applications electronically with APPLICATION FOR
ADVISORY COMMITTEE inserted in subject line to [email protected]. See
SUPPLEMENTARY INFORMATION for application requirements.
FOR FURTHER INFORMATION CONTACT: Elizabeth Van Osten, Designated
Federal Officer, Advisory Committee on Actuarial Examinations, at 202-
317-3648 or [email protected].
SUPPLEMENTARY INFORMATION:
1. Background
To qualify for enrollment to perform actuarial services under
ERISA, an applicant must satisfy certain experience and knowledge
requirements, which are set forth in the Joint Board's regulations. An
applicant may satisfy the knowledge requirement by successful
completion of Joint Board examinations in basic actuarial mathematics
and methodology and in actuarial mathematics and methodology relating
to pension plans qualifying under ERISA.
The Joint Board, the Society of Actuaries, and the American Society
of Pension Professionals & Actuaries jointly offer examinations
acceptable to
[[Page 72793]]
the Joint Board for enrollment purposes and acceptable to the other two
actuarial organizations as part of their respective examination
programs.
2. Scope of Advisory Committee Duties
The Advisory Committee plays an integral role in the examination
program by assisting the Joint Board in offering examinations that
enable examination candidates to demonstrate the knowledge necessary to
qualify for enrollment. The Advisory Committee's duties, which are
strictly advisory, include (1) recommending topics for inclusion on the
Joint Board examinations, (2) developing and reviewing examination
questions, (3) recommending proposed examinations, (4) reviewing
examination results and recommending passing scores, and (5) providing
other recommendations and advice relative to the examinations, as
requested by the Joint Board.
3. Member Terms and Responsibilities
Generally, members are appointed for a 2-year term. However, the
member selected pursuant to this notice will be appointed for 12
months, beginning March 1, 2024. Members may seek reappointment for
additional consecutive terms.
Members are expected to attend approximately 4 meetings each
calendar year and are reimbursed for travel expenses in accordance with
applicable government regulations. For this appointment, the member is
expected to attend approximately 4 meetings. Meetings may be held in-
person or by teleconference. In general, members are expected to devote
125 to 175 hours, including meeting time, to the work of the Advisory
Committee over the course of a year.
4. Member Selection
The Joint Board seeks to appoint an Advisory Committee that is
fairly balanced in terms of points of view represented and functions to
be performed. Every effort is made to ensure that most points of view
extant in the enrolled actuary profession are represented on the
Advisory Committee. To that end, the Joint Board seeks to appoint
members from each of the main practice areas of the enrolled actuary
profession, including small employer plans, large employer plans, and
multiemployer plans. In addition, to ensure diversity of points of
view, the Joint Board limits the number of members affiliated with any
one actuarial organization or employed with any one firm.
Membership normally will be limited to actuaries currently enrolled
by the Joint Board. However, individuals having academic or other
special qualifications of particular value for the Advisory Committee's
work also will be considered for membership. Federally registered
lobbyists and individuals affiliated with Joint Board enrollment
examination preparation courses are not eligible to serve on the
Advisory Committee.
5. Member Designation
Advisory Committee members are appointed as Special Government
Employees (SGEs). As such, members are subject to certain ethical
standards applicable to SGEs. Upon appointment, each member will be
required to provide written confirmation that he/she does not have a
financial interest in a Joint Board examination preparation course. In
addition, each member will be required to attend annual ethics
training.
6. Application Requirements
To receive consideration, an individual interested in serving on
the Advisory Committee must submit (1) a signed, cover letter
expressing interest in serving on the Advisory Committee and describing
his/her professional qualifications, and (2) a resume and/or curriculum
vitae. Applications must be submitted electronically to
[email protected]. The transmittal email should include APPLICATION FOR
ADVISORY COMMITTEE in the subject line. Applications must be received
by December 1, 2023.
Dated: October 18, 2023.
Thomas V. Curtin, Jr.,
Executive Director, Joint Board for the Enrollment of Actuaries.
[FR Doc. 2023-23328 Filed 10-20-23; 8:45 am]
BILLING CODE 4830-01-P
